INTRODUCTION
Dihydrolipoamide dehydrogenase (EC 1.8.1.4) catalyses the NAD+-dependent oxidation of dihydrolipoamide [reviewed by Williams (1976) ]: Dihydrolipoamide + NAD+ = lipoamide + NADH + H+
The enzyme fulfils this function in the pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase and branched-chain 2-oxo acid dehydrogenase complexes and is an integral component of each of these multienzyme structures. However, we have reported previously (Danson, 1984; Danson et al., 1984 Danson et al., , 1986 ) that, although archaebacteria do not possess these 2-oxo acid dehydrogenase complexes, they do have a dihydrolipoamide dehydrogenase, although its function in vivo remains unclear.
In the present paper we report our investigation of dihydrolipoamide dehydrogenase in the eukaryotic African parasite, Trypanosoma brucei. The bloodstream form of this trypanosome is totally dependent on glycolysis for ATP production, as it has no lipid or carbohydrate reserves and the mitochondrion does not possess a competent citric acid cycle (reviewed by Fairlamb, 1982) . Thus it does not have the NAD-linked 2-oxo acid dehydrogenase complexes, and under aerobic conditions glucose is metabolized almost completely to pyruvate, approx. 2 mol of pyruvate being produced per mol of glucose (Fairlamb, 1982) . T. brucei therefore provides us with a eukaryotic organism in which to look for the presence of dihydrolipoamide dehydrogenase in the absence of the 2-oxo acid dehydrogenase complexes. We not only report its presence and enzymological characteristics, but also show that it is associated with the plasma membrane of the trypanosome. The functional significance of its presence and cellular location is discussed.
EXPERIMENTAL

Materials
Chemicals used were of analytical grade or the finest grade commercially available. NAD+, NADP+ and NADH were from Boehringer, Mannheim, Germany; Nbs2 and type II-S soya-bean L-a-phosphatidylcholine were from Sigma Chemical Co., Poole, Dorset, U.K.; DL-lipoamide was from BDH Chemicals, Poole, Dorset, U.K.; and high-purity Triton X-100 was from Pierce and Warriner (U.K.), Chester, U.K. DL-Dihydrolipoamide was prepared by the reduction of DL-lipoamide with NaBH4 (Reed et al., 1958) , and p-aminophenyldichloroarsine (H2NPhAsCl2) was synthesized as described by Stevenson et al. (1978) . Growth and preparation of cells Cells of the long slender form of T. brucei were isolated from the blood of Wistar rats infected with 1 x 107-3 x 107 cells of strain MITat 1.1 by intraperitoneal injection as described by Eisenthal & Panes (1985) and were further purified by chromatography on DEAEcellulose (Lanham & Godfrey, 1970) . Cell extraction Cells (approx. 0.1 g wet wt.) were resuspended in 1 ml of 50 mM-potassium phosphate (pH 7.0)/2 mM-EDTA. The suspension was sonicated at 0°C for 3 x 30 s at 40 W with a 3 mm probe on an ultrasonic disintegrator; the cell debris was removed by centrifugation for 3 min at 10000 g (ray 5.5 cm) and the supernatant stored at 4 'C.
Enzyme assays
Dihydrolipoamide dehydrogenase was assayed at 30 'C in 50 mM-potassium phosphate (pH 7.0)/2 mM-EDTA containing 0.4 mM-dihydrolipoamide and 1 mM-NAD+. The reaction, in a final volume of 1 ml, was Abbreviation used: H2NPhAsC12, p-aminophenyldichloroarsine. t To whom all correspondence should be addressed.
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Malate dehydrogenase was assayed at 30°C in 50 mM-potassium phosphate (pH 7.0)/2 mM-EDTA containing 0.1 mM-NADH and 0.2 mM-oxaloacetate. The reaction, in a final volume of 1 ml, was started with enzyme and its progress was monitored by the decrease in A340. Chemical modification with H2NPhAsCl2
Modification of dihydrolipoamide dehydrogenase with 0.5 mM-H2NPhAsCl2 was carried out at 4°C in 50 mM-potassium phosphate (pH 7.0)/2 mM-EDTA and in the presence and absence of 50 ,uM-NADH. Preparation of trypanosomal plasma membrane Sheets of plasma membrane from T. brucei were prepared as described by Voorheis et al. (1979) . In outline, this procedure was as follows. Fresh trypanosomal cells were resuspended in 10 ml of Tes buffer (2 mM-Tes, pH 7.5, containing 150 mM-KCl, 1 mM-EGTA, 1 mM-2-mercaptoethanol and 0.1 mmphenylmethanesulphonyl fluoride). The cells were swelled by the addition of up to 30 ml of distilled water containing 0.1 mM-phenylmethanesulphonyl fluoride and 1O ,tg of leupeptin/ml (4°C) and were then homogenized in a tight-fitting glass Dounce homogenizer. Immediately after cell breakage, the ionic strength of the homogenate was restored by the addition of 2 ml of 3 M-KCI for every 40 ml of homogenate. The homogenate was then centrifuged at 7500 gav for 10 s to give a supernatant (S1) and pellet (P1). Pellet P1 was washed in the Tes buffer containing 10 jug ofleupeptin/ml and was then treated with DNAase as described by Voorheis et al. (1979) . The pellet (P2), collected by centrifugation (as above), was resuspended in 40% (w/v) sucrose in Tes buffer and centrifuged at 70000ga, for 3 h on a linear 40-60% sucrose gradient in the same buffer. Plasma-membrane sheets comprised the most prominent dense band; these were removed, washed three times in Tes buffer and finally resuspended in 50 mM-potassium phosphate (pH 7.0)/2 mM-EDTA. Assays of dihydrolipoamide dehydrogenase and malate dehydrogenase were carried out on the day of the preparation.
Preparation of Triton extract
Plasma membranes were incubated with 0.5% (w/v) Triton X-100 in 10 mM-Tris/HCl buffer, pH 7.4, for 20 min at 4 'C. After centrifugation at 20000 g for 60 min, the supernatant was treated with Bio-Beads SM-2 for 16 h (0.3 g wet wt. of beads/ml) at 4 'C.
Protein determination
Protein was measured by the method of Markwell et al. (1981) . Interference by the presence ofTriton X-100 was overcome by the addition of 3 % (w/v) SDS (Carruthers & Melchior, 1984) .
RESULTS
Presence of dihydrolipoamide dehydrogenase in T. brucei Dihydrolipoamide dehydrogenase activity was detected in cell-free extracts of T. brucei at a specific activity of 0.03 ,umol of NADH produced/min per mg of protein. (Fig. 1) lipoamide dehydrogenase was co-purified with the plasma membranes, with only 10% of the activity being retained in the supernatant (S1). This observation, that the enzyme is retained with the membrane sheets through a number of purification procedures and washing steps, strongly suggests a close interaction of dihydrolipoamide dehydrogenase with trypanosomal plasma membrane.
Treatment of the purified plasma membrane with 0.5% (w/v) Triton X-100 resulted in > 80% of the dihydrolipoamide dehydrogenase being recovered in the supernatant after centrifugation and removal of the detergent by Bio-Beads (Fig. 1) .
To provide a positive identification of the nature of the membrane in the final washed pellet, we have monitored throughout the preparation the ouabain-sensitive Na+ + K+-stimulated ATPase, which Voorheis et al. (1979) In both sonicated cell-free extracts and purified plasma membrane, the enzyme showed a hyperbolic dependence (Eisenthal & Cornish-Bowden, 1974) , and the kinetic constants determined are summarized in Table 1 . There were no significant differences in Km values between the two enzyme preparations, although the specific activity in the plasma membrane was 8-fold greater than that observed in the sonicated cell-free extracts. This increase in specific activity compares with reported values of 15-fold for ouabain-sensitive Na+ + K+-stimulated ATPase and 5-fold for adenylate cyclase (Voorheis et al., 1979) . Chemical modification of dihydrolipoamide dehydrogenase with H2NPhAsCI2
The catalytic mechanism of dihydrolipoamide dehydrogenase normally involves the alternate oxidation and reduction of an intrachain disulphide bond (Williams, 1976) . Thus its ligands dihydrolipoamide and NADH will render the active-site disulphide bond susceptible to dithiol-specific tervalent arsenicals (Adamson & Stevenson, 1981; Adamson et al., 1984) , a phenomenon which is characteristic of this enzyme and which may be used to help establish that the observed enzymic activity is the result of a true dihydrolipoamide dehydrogenase.
In accordance with the normal catalytic mechanism, the enzyme from both cell-free extracts and purified plasma membrane was rapidly inactivated by H2NPhAsCl2 in the presence of NADH (Fig. 2) , whereas the reagent alone caused no significant loss of enzymic activity.
DISCUSSION
The data in the present paper constitute the first report of the presence of dihydrolipoamide dehydrogenase in T. brucei. The significance of this discovery stems from a number of observations. Firstly, the bloodstream form of T. brucei does not have the pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes (Fairlamb, 1982 T. brucei suggests that this enzyme may have an additional metabolic role, which remains to be elucidated. This is the first time that the enzyme has been found in the absence of the 2-oxo acid dehydrogenase complexes in a eukaryotic organism, although we have previously reported a similar situation in the halophilic (Danson et al., , 1986 , thermoacidophilic and methanogenic (Danson, 1984) archaebacteria. We have purified dihydrolipoamide dehydrogenase from Halobacterium halobium (Danson et al., 1986) and find it to be remarkably similar to its counterpart in non-archaebacterial species in subunit arrangement and in its catalytic and kinetic properties. Similarly, in the present paper, we demonstrate that dihydrolipoamide dehydrogenase from T. brucei specifically catalyses the stoichiometric oxidation of dihydrolipoamide by NAD+, and we provide evidence from chemical modification studies that a reversibly reducible disulphide bond is essential to catalysis, as has been found in other dihydrolipoamide dehydrogenases (Williams, 1976) .
It should be noted that Ryley (1962) found that oxidized lipoic acid increased the rate of oxidation of NADH by homogenates of Trypanosoma rhodesiense, indicating the presence of dihydrolipoamide dehydrogenase in this trypanosome. However, the organism can also metabolize pyruvate to CO2 and it may be that the enzyme is functioning in its recognized role in pyruvate oxidation in T. rhodesiense, a situation not occurring in T. brucei.
A second significant factor is that T. brucei dihydrolipoamide dehydrogenase appears to be located specifically in the plasma membranes of the organism. Our evidence for this comes from the co-purification of the enzyme with the plasma membrane. Moreover, in preliminary experiments, we have shown, by the method of Kasahara & Hinkle (1977) , that dihydrolipoamide dehydrogenase, extracted from the purified plasma membranes with Triton X-100, can be reconstituted into soya-bean L-a-phosphatidylcholine liposomes to a specific activity the same as that in the purified membranes (K. Conroy, M. J. Danson, R. Eisenthal & G. Holman, unpublished work) . This is the first time that a eukaryotic dihydrolipoamide dehydrogenase has been reported to be membrane-associated, and such an attachment may suggest a function specific to that location. Indeed, evidence has been presented (Richarme, 1985; Richarme & Heine, 1986 ) that lipoic acid and dihydrolipoamide dehydrogenase may be involved in the Escherichia coli binding-protein-dependent transport of galactose and maltose. In this system, the enzyme is distinct from the Lpd gene product, which functions in the 2-oxo acid dehydrogenase complexes (Richarme & Heine, 1986) . Additionally, it has been observed that the dithiol-specific tervalent arsenical phenylarsine oxide inactivates insulinstimulated hexose transport by 3T3-L1 adipocytes (Frost & Lane, 1985) . These authors noted that this inactivation of hexose transport had similar characteristics to the inactivation of 2-oxo acid dehydrogenases by the same arsenical (reacting with the lipoyl groups on the acetyltransferase component); however, the site of reaction of phenylarsine oxide with the adipocytes has not yet been defined.
An assay for the transport of glucose into T. brucei has now been developed (Game et al., 1986 ). It should therefore be possible to determine the effects of tervalent arsenical reagents on this system and so to investigate whether or not dihydrolipoamide dehydrogenase is associated with transport in trypanosomes. It would also be of interest to look for the presence and cellular location of the enzyme's normal substrate, lipoic acid, in T. brucei. To this end, we have developed a method using g.l.c.-mass spectrometry to detect lipoic acid as its oxidized lipoate methyl ester (Danson et al., 1985) .
In conclusion, there is growing evidence that dihydrolipoamide dehydrogenase has a cellular function in addition to its established role in the 2-oxo acid dehydrogenase complexes. It is considered that further studies of the enzyme in the archaebacteria and T. brucei, where the multienzyme complexes are not found, will be valuable in identifying this new function.
